Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statementThamer Sliwa, Heinz Gisslinger, Stefan Wöhrer et al.|Wiener klinische Wochenschrift|2016Cited by 9
Ruxolitinib therapy for myelofibrosis in AustriaMaria‐Theresa Krauth, Heinz Gisslinger, Sonja Burgstaller et al.|Wiener klinische Wochenschrift|2018Cited by 6
Austrian recommendations for the management of polycythemia veraSonja Burgstaller, Heinz Gisslinger, Veronika Buxhofer‐Ausch et al.|Wiener klinische Wochenschrift|2018Cited by 4
Austrian recommendations for the management of essential thrombocythemiaVeronika Buxhofer‐Ausch, Heinz Gisslinger, Sonja Heibl et al.|Wiener klinische Wochenschrift|2020Cited by 2
Correction to: Ruxolitinib therapy formyelofibrosis in AustriaMaria‐Theresa Krauth, Heinz Gisslinger, Sonja Burgstaller et al.|Wiener klinische Wochenschrift|2018Cited by 0